Evidence map›Paper›PMID 26283505›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2016

The role of active brown adipose tissue in human metabolism.

Salih Ozguven, Tunc Ones, Yusuf Yilmaz, H Turgut Turoglu, Nese Imeryuz

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03875625 (Change of Adipose Tissues and Triglyceride in Obese Patients With Non-alcoholic Fatty Liver Disease After Bariatric Surgery or Life-style Intervention), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03875625 narecruitingnot on this mapstarted 2019, after this paper: background citation

Change of Adipose Tissues and Triglyceride in Obese Patients With Non-alcoholic Fatty Liver Disease After Bariatric Surgery or Life-style Intervention

TypeinterventionalSponsorChinese University of Hong KongRan2019 to 2026Enrolled80ConditionsNon-Alcoholic Fatty Liver Disease, Obesity, Morbid, Brown Fat, Metabolic DiseaseArmsBariatric surgery, Dietitian led life style modification intervention, Conventional care (control)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Indication of mixed glucose and fatty acid use by inferred brown adipose tissue activity in Samoans.American journal of human biology : the official journal of the Human Biology Council · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Brown and Beige Adipose Tissue: Therapy for Obesity and Its Comorbidities?Endocrinology and metabolism clinics of North America · 2016
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Salih OzguvenDepartment of Nuclear Medicine, S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey.
Tunc OnesDepartment of Nuclear Medicine, S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey. tones@marmara.edu.tr.
Yusuf YilmazDepartment of Internal Medicine, Division of Gastroenterology, S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey.
H Turgut TurogluDepartment of Nuclear Medicine, S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey.
Nese ImeryuzDepartment of Internal Medicine, Division of Gastroenterology, S.B. Marmara Universitesi Pendik Egitim ve Arastirma Hastanesi, Istanbul, Turkey.
Marmara Üniversitesi Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe presence of activated brown adipose tissue (ABAT) has been associated with a reduced risk of obesity in adults. We aimed to investigate whether the presence of ABAT in patients undergoing (18)F-FDG PET/CT examinations was related to blood lipid profiles, liver function, and the prevalence of non-alcoholic fatty liver disease (NAFLD).

methodsWe retrospectively and prospectively analysed the (18)F-FDG PET/CT scans from 5,907 consecutive patients who were referred to the Nuclear Medicine Department of the Marmara University School of Medicine from outpatient oncology clinics between July 2008 and June 2014 for a variety of diagnostic reasons. Attenuation coefficients for the liver and spleen were determined for at least five different areas. Blood samples were obtained before PET/CT to assess the blood lipid profiles and liver function.

resultsA total of 25 of the 5,907 screened individuals fulfilling the inclusion criteria for the study demonstrated brown fat tissue uptake [ABAT(+) subjects]. After adjustment for potential confounders, 75 individuals without evidence of ABAT on PET [ABAT(-) subjects] were enrolled for comparison purposes. The ABAT(+) group had lower total cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, and aspartate transaminase levels (p < 0.01), whereas we found no significant differences in the serum triglyceride and high-density lipoprotein cholesterol levels between the two groups. The prevalence of NAFLD was significantly lower in ABAT(+) than in ABAT(-) subjects (p < 0.01).

conclusionOur study showed that the presence of ABAT in adults had a positive effect on their blood lipid profiles and liver function and was associated with reduced prevalence of NAFLD. Thus, our data suggest that activating brown adipose tissue may be a potential target for preventing and treating dyslipidaemia and NAFLD.

Indexed as

Adipose Tissue, BrownAdultDyslipidemiasFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedMultimodal ImagingNon-alcoholic Fatty Liver DiseasePositron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedFluorodeoxyglucose F18Radiopharmaceuticals18F-FluorodeoxyglucoseAdipose tissue, brownDyslipidaemiasNon-alcoholic fatty liver diseasePositron emission tomography

Identifiers

PMID26283505
OpenAlexW1514156748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.